Nkhani

Pa Marichi 12^th 2022, ndiNMPA (SFDA) adapereka chidziwitso chovomereza kusintha kwa ntchito yodziyesa yokha zinthu za antigen za COVID-19 ndi Nanjing Vazyme BiotechCo., Ltd, Beijing Jinwofu Bioengineering TechnologyCo., Ltd, Malingaliro a kampani Shenzhen Huada Yinyuan Pharmaceutical Technology Co., Ltd, Malingaliro a kampani Guangzhou Wondfo Biotech Co., Ltd ndiBMalingaliro a kampani eijing Savant Biotechnology Co., Ltd(Uwuketai). Zinthu zisanu zodziyesera zokha za COVID-19 zakhazikitsidwa.

Pa Marichi 11, 2022, NHC idalengeza kuti, pofuna kupititsa patsogolo njira yoyezetsa matenda a Novel Coronavirus ndikukwaniritsa zofunikira za kupewa ndi kuwongolera COVID-19, Gulu Lonse la Gulu Lophatikiza Kupewa ndi Kuwongolera la State Council lidaganiza zowonjezera. kuyesa kwa antigen ku kuyesa kwa nucleic acid ndikupanga" Application Protocol for Novel Coronavirus Antigen Detection (Trial)"
Protocol imatchula anthu omwe akuyenera kuyesa ma antigen:
Choyamba, iwo omwe amapita ku zipatala zoyambirira zachipatala ndipo amakhala ndi zizindikiro monga kupuma ndi kutentha thupi mkati mwa masiku 5 chiyambireni zizindikiro;
Chachiwiri, ogwira ntchito yoyang'anira kukhala kwaokha, kuphatikiza kuyang'anira anthu okhala kwaokha, kuyandikira pafupi ndi kuyandikira pafupi, kuyang'anira anthu okhala kwaokha, malo okhalamo ndi ogwira ntchito m'malo owongolera;
Chachitatu ndi anthu ammudzi omwe ali ndi vuto lodzizindikiritsa okha antigen.

Malangizo: Kuzindikira kwa antigen ndi gawo lofunikira pakuzindikira kwa nucleic acid, koma zotsatira za antigen kudzizindikira sizingagwiritsidwe ntchito ngati maziko a matenda.